Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SOL SpAMIL:SOL +0.92%80 3-Year EBITDA Growth Rate is 11.10% as of Dec. 2025, which is 23% above its 10-year median of 9.00. GuruFocus rates MIL:SOL with a GF Score™ of 80/100 and a GF Value™ of €42.84 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 1,408 Chemicals companies, SOL SpA ranks better than 69.18% on this metric.
During the past 12 months, SOL SpA's average EBITDA Per Share Growth Rate was 11.30% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 11.10% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 12.90% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 12.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of SOL SpA was 17.80% per year. The lowest was 1.00% per year. And the median was 9.00% per year.
SOL SpA (MIL:SOL) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
SOL SpA 3-Year EBITDA Growth Rate Related Terms
MIL:SOL vs LIN, SHW, ECL: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, SOL SpA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOL SpA 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, SOL SpA's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where SOL SpA's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 11.10% mean?
SOL SpA (MIL:SOL) has a 3-Year EBITDA Growth Rate of 11.10% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for SOL SpA and its competitors. This is 23% above median its historical median of 9.00. Over the past decade, SOL SpA's 3-Year EBITDA Growth Rate has ranged from 1.00 to 17.80. According to the industry distribution chart, SOL SpA ranks #434 out of 1408 companies in the Chemicals industry, placing it in the top 30.8%.
Is SOL SpA's 3-Year EBITDA Growth Rate too high?
SOL SpA's current 3-Year EBITDA Growth Rate of 11.10% is 23% above median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 17.80. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.85. SOL SpA's value of 11.10% is 1205.9% above this industry median. Based on the distribution chart, SOL SpA ranks #434 out of 1408 companies in the Chemicals industry, which is above the industry midpoint. Overall, SOL SpA has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOL SpA's 3-Year EBITDA Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, SOL SpA ranks #434 out of 1408 companies for 3-Year EBITDA Growth Rate. This puts SOL SpA in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 0.85. SOL SpA's value of 11.10% is 1205.9% above this benchmark. Historically, SOL SpA's own 3-Year EBITDA Growth Rate has ranged from 1.00 to 17.80 over the past decade. While the company's 10-year median is 9.00 vs. the industry median of 0.85, SOL SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.85, based on 1,408 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SOL SpA's current 3-Year EBITDA Growth Rate of 11.10% is 1205.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for SOL SpA and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOL SpA's current 3-Year EBITDA Growth Rate is 11.10%, which is 23% above median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOL SpA stock overvalued right now?
Based on GuruFocus' analysis, SOL SpA (MIL:SOL) is currently considered Modestly Overvalued. The stock's GF Value™ is €42.84, compared to a current price of €54.90 — trading 28.2% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 11.10%, which is 23% above median its 10-year median of 9.00 and 1205.9% above the Chemicals industry median of 0.85. SOL SpA's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For SOL SpA (MIL:SOL), the current 3-Year EBITDA Growth Rate is 11.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SOL SpA (MIL:SOL) Overvalued in 2026?
Based on GuruFocus' analysis, SOL SpA stock appears to be overvalued.
The current stock price of €54.90 is trading 28.2% above its estimated GF Value™ of €42.84.
GuruFocus considers SOL SpA to be Modestly Overvalued.
Key valuation signals for MIL:SOL:
3-Year EBITDA Growth Rate: 11.10% (23% above median its 10-year median of 9.00)
GF Value™: €42.84 vs. price of €54.90 (28.2% above fair value)
Industry Position: 1205.9% above the Chemicals median (#434 of 1408)
No single metric tells the full story. See the MIL:SOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SOL SpA manufactures and sells industrial gases and medical equipment. The firm's two segments are based on product type. The home-care segment, which generates the majority of revenue, sells a variety of medicinal gases including oxygen, nitrogen, nitrous oxide, carbon dioxide, synthetic air, and medical air. The segment also provides medical air services for hospitals. The technical gases segment sells gas-based products to the energy, agricultural, food, metalworking, glass, and electronics industries. More of SOL's revenue comes from Italy than any other country.
80GF Score
Get the complete analysis for MIL:SOL
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:SOL has been successfully added to your 
